Home
About
Overview
Sharing Data
ORCID
Help
History (9)
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease.
Althaea
Acinetobacter baumannii
Dideoxynucleosides
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578).
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578). Cancer Treat Rep. 1982 Jun; 66(6):1417-9.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Small Cell
Cisplatin
Drug Evaluation
Female
Humans
Lung Neoplasms
Male
Maytansine
Middle Aged
Streptozocin